[go: up one dir, main page]

PE20080348A1 - Moduladores tiazolopirimidina de trpv1 - Google Patents

Moduladores tiazolopirimidina de trpv1

Info

Publication number
PE20080348A1
PE20080348A1 PE2007000838A PE2007000838A PE20080348A1 PE 20080348 A1 PE20080348 A1 PE 20080348A1 PE 2007000838 A PE2007000838 A PE 2007000838A PE 2007000838 A PE2007000838 A PE 2007000838A PE 20080348 A1 PE20080348 A1 PE 20080348A1
Authority
PE
Peru
Prior art keywords
phenyl
alkyl
pyrimidin
diamine
trifluoromethyl
Prior art date
Application number
PE2007000838A
Other languages
English (en)
Inventor
Bryan James Branstetter
James Guy Breitenbucher
Alec D Lebsack
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38740251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080348(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PE20080348A1 publication Critical patent/PE20080348A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE TIAZOLOPIRIMIDINA DE FORMULA I DONDE R1 ES H, ALQUILO C1-C6, O-(ALQUILO C1-C6), S-(ALQUILO C1-C6), ENTRE OTROS; R2 ES H, ALQUILO C1-C6; R3 ES CICLOALQUILO MONOCICLICO, FENILO, BENCILO, INDANILO, ENTRE OTROS; R4 ES H, ALQUILO C1-C6; R5 ES FENILO, HETEROARILO MONOCICLICO DE 5 MIEMBROS O HETEROARILO MONOCICLICO DE 6 MIEMBROS SUSTITUIDO O NO. SON COMPUESTOS PREFERIDOS: N2-(2,6-DICLORO-FENIL)-N7-(4-TRIFLUOROMETIL-FENIL)-TIAZOLO[5,4-d]PIRIMIDIN-2,7-DIAMINA; N2-o-TOLIL-N7-(4-TRIFLUOROMETIL-FENIL)-TIAZOLO[5,4-d]PIRIMIDIN-2,7-DIAMINA; 5-METIL-N2-(5-METIL-3-FENIL-ISOXAZOL-4-IL)-N7-(6-TRIFLUOROMETIL-PIRIDIN-3-IL)-TIAZOLO[5,4-d]PIRIMIDIN-2,7-DIAMINA; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION Y UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO ES UN MODULADOR DE TRPV1 LIGADA A NOCICEPTORES Y ES UTIL EN EL TRATAMIENTO DEL DOLOR, PRURITO, TOS Y OTROS ESTADOS INFLAMATORIOS
PE2007000838A 2006-06-30 2007-07-02 Moduladores tiazolopirimidina de trpv1 PE20080348A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81815306P 2006-06-30 2006-06-30

Publications (1)

Publication Number Publication Date
PE20080348A1 true PE20080348A1 (es) 2008-04-25

Family

ID=38740251

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000838A PE20080348A1 (es) 2006-06-30 2007-07-02 Moduladores tiazolopirimidina de trpv1

Country Status (8)

Country Link
US (1) US20080004253A1 (es)
EP (1) EP2044086A2 (es)
AR (1) AR061761A1 (es)
CL (1) CL2007001921A1 (es)
PE (1) PE20080348A1 (es)
TW (1) TW200821320A (es)
UY (1) UY30454A1 (es)
WO (1) WO2008005303A2 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009073153A2 (en) * 2007-11-28 2009-06-11 Dana Farber Cancer Institute Small molecule myristate inhibitors of bcr-abl and methods of use
CL2008003749A1 (es) 2007-12-17 2010-01-15 Janssen Pharmaceutica Nv Compuestos derivados de imidazol, oxazol, y tiazol pirimidina, moduladores de trpv1, proceso de preparacion, composicion farmaceutica y su uso en el tratamiento de enfermedades, trastornos o condicion de dolor, prurito, artritis, tos, asma, trastorno del oido interno y enfermedad inflamatoria intestinal, entre otras.
US20090156598A1 (en) * 2007-12-17 2009-06-18 Lebsack Alec D Imidazolopyrimidine modulators of TRPV1
RU2522430C2 (ru) * 2008-01-22 2014-07-10 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи 5-фторпиримидиновые производные в качестве фунгицидов
WO2010093704A1 (en) * 2009-02-10 2010-08-19 Abbott Laboratories Agonists and antagonists of the s1p5 receptor, and methods of uses thereof
JP5647998B2 (ja) * 2009-03-13 2015-01-07 カトリーケ ユニバーシテイト ルーヴェン、ケー．ユー． ルーヴェン アール アンド ディー 免疫抑制剤としてのチアゾロピリミジン調節因子
CN104945420A (zh) 2009-06-29 2015-09-30 因塞特公司 作为pi3k抑制剂的嘧啶酮类
UA112284C2 (uk) * 2009-08-07 2016-08-25 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні 5-фторпіримідинону
UA107671C2 (en) 2009-08-07 2015-02-10 Dow Agrosciences Llc N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
PE20120691A1 (es) * 2009-08-07 2012-06-08 Dow Agrosciences Llc Derivados de n1-sulfonil-5-fluoropirimidinona
UA106889C2 (uk) * 2009-08-07 2014-10-27 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі Похідні n1-ацил-5-фторпіримідинону
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
KR101814835B1 (ko) 2010-01-07 2018-01-04 다우 아그로사이언시즈 엘엘씨 티아졸로［5,4-ｄ］피리미딘 및 그의 농약으로서의 용도
WO2011130342A1 (en) 2010-04-14 2011-10-20 Incyte Corporation FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
CA2822070C (en) 2010-12-20 2019-09-17 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
CN103946226A (zh) 2011-07-19 2014-07-23 无限药品股份有限公司 杂环化合物及其应用
US8658660B2 (en) 2011-08-17 2014-02-25 Dow Agrosciences, Llc. 5-fluoro-4-imino-3,4-dihydropyrimidin-2-(1H)-ones derivatives
AR087760A1 (es) 2011-09-02 2014-04-16 Incyte Corp Heterociclilaminas como inhibidores de pi3k
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP2938194B1 (en) 2012-12-28 2019-11-27 Adama Makhteshim Ltd. N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2h)-carboxylate derivatives
US9321734B2 (en) 2012-12-28 2016-04-26 Dow Agrosciences Llc N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1(2H)-carboxamide derivatives
CN104994859B (zh) 2012-12-28 2018-10-26 阿达玛马克西姆股份有限公司 1-(取代的苯甲酰基)-5-氟-4-亚氨基-3-甲基-3,4-二氢嘧啶-2(1h)-酮衍生物
RU2644014C2 (ru) 2012-12-31 2018-02-07 Адама Мактешим Лтд. Производные 3-алкил-5-фтор-4-замещенного-имино-3,4-дигидропиримидин-2(н)-она в качестве фунгицидов
RU2016110852A (ru) * 2013-09-27 2017-10-30 Нимбус Айрис, Инк. Ингибиторы irak и их применения
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
HUE057734T2 (hu) 2013-10-04 2022-06-28 Infinity Pharmaceuticals Inc Heterociklusos vegyületek és alkalmazásuk
CN103694243B (zh) * 2013-12-20 2015-09-09 中国农业大学 2-取代吡啶基-1,2,4-三唑并[1,2-a]哒嗪化合物
WO2015103261A1 (en) 2013-12-31 2015-07-09 Dow Agrosciences Llc Synergistic fungicidal mixtures for fungal control in cereals
UA122200C2 (uk) 2013-12-31 2020-10-12 Адама Махтешім Лтд. 5-фтор-4-іміно-3-(алкіл/заміщений алкіл)-1-(арилсульфоніл)-3,4-дигідропіримідин-2(1h)-он і способи його одержання
CN113616656B (zh) 2014-03-19 2023-02-17 无限药品股份有限公司 用于治疗PI3K-γ介导的障碍的杂环化合物
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
PT3831833T (pt) 2015-02-27 2023-02-06 Incyte Corp Processos para a preparação de um inibidor pi3k
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
EP3350183B1 (en) 2015-09-14 2025-04-02 Twelve Therapeutics, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3655396A1 (en) 2017-07-17 2020-05-27 Adama Makhteshim Ltd. Polymorphs of 5-fluoro-4-imino-3-methyl-1-tosyl-3,4-dihydropyrimidin-2-one
KR102884803B1 (ko) 2018-06-01 2025-11-12 인사이트 코포레이션 Pi3k 관련 장애의 치료를 위한 투여 요법
CN111187181B (zh) * 2019-11-22 2023-05-05 吉林大学 一种2-(4-氨基苯基)-2-甲基丙腈化合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107300A (en) * 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
ATE419239T1 (de) * 2000-10-20 2009-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung von 4-phenoxy chinolin derivaten
AU2004212490B2 (en) * 2003-02-10 2008-05-15 Amgen Inc. Vanilloid receptor ligands and their use in treatments
KR20060118398A (ko) * 2003-08-05 2006-11-23 버텍스 파마슈티칼스 인코포레이티드 전압 개폐 이온 채널 억제제로서의 축합 피라미딘 화합물
EP1678173A2 (en) * 2003-09-09 2006-07-12 Neurogen Corporation 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists
EP1670794A2 (en) * 2003-09-30 2006-06-21 Amgen Inc. Vanilloid receptor ligands and their use in treatments
JP2007507494A (ja) * 2003-10-07 2007-03-29 アストラゼネカ・アクチエボラーグ ケモカイン受容体アンタゴニストとりわけＣＸ３ＣＲ１として有用な新規な２−置換４−アミノ−チアゾロ［４，５−ｄ］ピリミジン
AU2006278627B2 (en) * 2005-08-08 2011-08-18 Janssen Pharmaceutica, N.V. Thiazolopyrimidine kinase inhibitors

Also Published As

Publication number Publication date
EP2044086A2 (en) 2009-04-08
AR061761A1 (es) 2008-09-17
US20080004253A1 (en) 2008-01-03
CL2007001921A1 (es) 2008-03-14
UY30454A1 (es) 2008-01-31
TW200821320A (en) 2008-05-16
WO2008005303A3 (en) 2008-04-10
WO2008005303A2 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
PE20080348A1 (es) Moduladores tiazolopirimidina de trpv1
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20080830A1 (es) Compuestos derivados de sulfonilo que modulan el receptor cb2
PE20090042A1 (es) Analogos de ciclopamina
PE20061436A1 (es) Derivados de amida sustituida como inhibidores de proteina quinasa
EA200601660A1 (ru) Ингибирующие mtp арилпиперидины или пиперазины, замещенные 5-членными гетероциклами
EA200870196A1 (ru) Индолсульфонамидные модуляторы рецепторов прогестерона
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
UY30013A1 (es) 5-aril isoxazolinas para controlar plagas de invertebrados
ECSP088397A (es) Derivados de amida heterociclica útiles como microbiocidas
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
PE20080145A1 (es) Tetrahidro-pirimidoazepinas como moduladores de trpv1
PE20090620A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
EA201070018A1 (ru) Замещенные 2-[2-(фенил)этиламино] алканамидные производные и применение указанных соединений в качестве модуляторов натриевых и/или кальциевых каналов
PE20050226A1 (es) Productos aril-heteroaromaticos y composiciones que los contienen
PE20070592A1 (es) Derivados de prolinamida como moduladores de canales de sodio
CL2022003625A1 (es) Compuestos naftaleno isoxazolina para controlar plagas invertebradas (divisional de patente de invención no 2073-2020)
NO20081169L (no) Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
PE20080342A1 (es) Inhibidores de proteasa de hiv de 2-(amino-sustituido)-benzotiazol sulfonamida
PE20090712A1 (es) Moduladores de la gamma secretasa
BRPI0813809A2 (pt) derivados de 7-alquinil -1,8-naftiridonas, sua preparação e sua aplicação em terapêutica.
SE0300092D0 (sv) Novel compounds
DE602006019221D1 (de) Von dopamin-d3-rezeptoren
PE20070495A1 (es) COMPUESTOS DERIVADOS DE alfa-AMINOCARBOXIAMIDA CUATERNARIOS COMO MODULADORES DE LOS CANALES DE SODIO CON APERTURA POR VOLTAJE
DK1730147T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme

Legal Events

Date Code Title Description
FX Voluntary withdrawal